Published in J Virol on September 11, 2013
Primary Prevention of Infection by COVID-19 in Health Providers (PI-Covid-19) | NCT04420260
Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev (2015) 1.64
Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci U S A (2014) 1.27
Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection. J Virol (2014) 1.25
Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci U S A (2014) 1.20
Tmprss2 is essential for influenza H1N1 virus pathogenesis in mice. PLoS Pathog (2013) 1.09
The host protease TMPRSS2 plays a major role in in vivo replication of emerging H7N9 and seasonal influenza viruses. J Virol (2014) 1.05
High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus. J Virol (2015) 0.96
Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J (2014) 0.92
Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis. Virus Res (2014) 0.92
Coronaviruses - drug discovery and therapeutic options. Nat Rev Drug Discov (2016) 0.91
DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry. J Virol (2014) 0.88
Simian hemorrhagic fever virus cell entry is dependent on CD163 and uses a clathrin-mediated endocytosis-like pathway. J Virol (2014) 0.86
Cell-based antiviral screening against coronaviruses: developing virus-specific and broad-spectrum inhibitors. Antiviral Res (2013) 0.82
A camel-derived MERS-CoV with a variant spike protein cleavage site and distinct fusion activation properties. Emerg Microbes Infect (2016) 0.81
Middle East respiratory syndrome: obstacles and prospects for vaccine development. Expert Rev Vaccines (2015) 0.80
Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol (2016) 0.80
Fusion of Enveloped Viruses in Endosomes. Traffic (2016) 0.80
Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism. Proc Natl Acad Sci U S A (2016) 0.80
The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent. PLoS One (2016) 0.79
Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells. J Gen Virol (2015) 0.79
Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome (MERS) corona virus S-mediated membrane fusion using the split protein-based cell-cell fusion assay. Antimicrob Agents Chemother (2016) 0.77
Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry. J Virol (2016) 0.77
Respiratory protease/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants. Am J Physiol Lung Cell Mol Physiol (2015) 0.77
Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus. J Infect Dis (2015) 0.76
Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains. J Virol (2015) 0.75
Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen. Front Microbiol (2016) 0.75
Cell Entry of Porcine Epidemic Diarrhea Coronavirus Is Activated by Lysosomal Proteases. J Biol Chem (2016) 0.75
TMPRSS2 Isoform 1 Activates Respiratory Viruses and Is Expressed in Viral Target Cells. PLoS One (2015) 0.75
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. J Virol (2016) 0.75
Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice. Proc Natl Acad Sci U S A (2017) 0.75
Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection. Virol J (2017) 0.75
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A (2017) 0.75
Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med (2012) 22.75
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol (2013) 4.98
Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis (2013) 4.28
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio (2012) 3.96
Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A (2004) 3.03
Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol (2006) 2.80
The spike protein of the emerging betacoronavirus EMC uses a novel coronavirus receptor for entry, can be activated by TMPRSS2, and is targeted by neutralizing antibodies. J Virol (2013) 2.10
Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol (2009) 2.05
Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc Natl Acad Sci U S A (2005) 1.85
TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells. J Virol (2010) 1.66
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol (2010) 1.44
Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol (2010) 1.40
A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry. J Virol (2010) 1.40
Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol (2008) 1.37
Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. J Virol (2011) 1.37
Novel insights into proteolytic cleavage of influenza virus hemagglutinin. Rev Med Virol (2010) 1.34
Type II transmembrane serine proteases in cancer and viral infections. Trends Mol Med (2009) 1.25
Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS One (2012) 1.24
Role of proteases in the release of porcine epidemic diarrhea virus from infected cells. J Virol (2011) 1.14
Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection. PLoS One (2010) 1.13
MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine (2009) 1.13
Protease-mediated entry via the endosome of human coronavirus 229E. J Virol (2008) 1.09
Novel coronavirus associated with severe respiratory disease: case definition and public health measures. Euro Surveill (2012) 1.08
Two-step conformational changes in a coronavirus envelope glycoprotein mediated by receptor binding and proteolysis. J Virol (2009) 1.05
Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol (2012) 1.04
Identification of the fusion-from-without determinants of herpes simplex virus type 1 glycoprotein B. Virology (1997) 0.92
Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein. J Virol (2006) 4.24
Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol (2010) 1.44
Soluble receptor potentiates receptor-independent infection by murine coronavirus. J Virol (2002) 1.17
Entry from the cell surface of severe acute respiratory syndrome coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J Virol (2008) 1.16
Role of proteases in the release of porcine epidemic diarrhea virus from infected cells. J Virol (2011) 1.14
Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J Gen Virol (2005) 1.09
Protease-mediated entry via the endosome of human coronavirus 229E. J Virol (2008) 1.09
Detection of bat coronaviruses from Miniopterus fuliginosus in Japan. Virus Genes (2011) 1.08
Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. J Virol (2012) 1.04
Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP). Virol J (2014) 0.92
TMPRSS2 is an activating protease for respiratory parainfluenza viruses. J Virol (2013) 0.86
Recombinant nucleocapsid protein-based IgG enzyme-linked immunosorbent assay for the serological diagnosis of SARS. J Virol Methods (2005) 0.84
Characterization of a variant virus from ascitic fluid of subacute granulomatous serositis in interferon-gamma-deficient C57BL/6 mice persistently infected with murine coronavirus strain JHM. Viral Immunol (2010) 0.83
Mutation in the cytoplasmic retrieval signal of porcine epidemic diarrhea virus spike (S) protein is responsible for enhanced fusion activity. Virus Res (2011) 0.82
Differences in neutralizing antigenicity between laboratory and clinical isolates of HCoV-229E isolated in Japan in 2004-2008 depend on the S1 region sequence of the spike protein. J Gen Virol (2012) 0.81
Receptor-independent infection of murine coronavirus: analysis by spinoculation. J Virol (2006) 0.81
Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein. Adv Exp Med Biol (2006) 0.77
Middle East respiratory syndrome coronavirus infection not found in camels in Japan. Jpn J Infect Dis (2015) 0.76
Two palmitylated cysteine residues of the severe acute respiratory syndrome coronavirus spike (S) protein are critical for S incorporation into virus-like particles, but not for M-S co-localization. J Gen Virol (2012) 0.76
Increased replication of respiratory syncytial virus in the presence of cytokeratin 8 and 18. J Med Virol (2012) 0.75
[Cell entry mechanisms of coronaviruses]. Uirusu (2009) 0.75
Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease. J Med Virol (2014) 0.75
Spongiform degeneration induced by neuropathogenic murine coronavirus infection. Pathol Int (2011) 0.75
Receptor-independent infection by mutant viruses newly isolated from the neuropathogenic mouse hepatitis virus srr7 detected through a combination of spinoculation and ultraviolet radiation. Jpn J Infect Dis (2011) 0.75